Nishadil
Signup Signin
Delhi | 25°C (windy)
Navigating Archean Chemical: Deven Choksey's “Hold” Perspective

Navigating Archean Chemical: Deven Choksey's “Hold” Perspective
Vishnu Chemicals: Why Analysts See Bright Prospects and Significant Upside

Vishnu Chemicals: Why Analysts See Bright Prospects and Significant Upside
Poonawalla Fincorp: Why Motilal Oswal Sees a Bright Future and Rs 600 Target

Poonawalla Fincorp: Why Motilal Oswal Sees a Bright Future and Rs 600 Target
Cello World's Unseen Spark: Why Analysts Are Seeing Gold in Everyday Items

Cello World's Unseen Spark: Why Analysts Are Seeing Gold in Everyday Items
The Unfolding Narrative of Syrma SGS: Why One Brokerage Sees a Bright Horizon

The Unfolding Narrative of Syrma SGS: Why One Brokerage Sees a Bright Horizon
The Quiet Innovator: Why Syrma SGS Might Just Be Your Next Smart Bet

The Quiet Innovator: Why Syrma SGS Might Just Be Your Next Smart Bet
The Quiet Ascent: Why JB Chemicals is Catching Analysts' Eyes with a Bold Target

The Quiet Ascent: Why JB Chemicals is Catching Analysts' Eyes with a Bold Target
KIMS on the Rise: Why Analysts See Bright Prospects for This Hospital Chain

KIMS on the Rise: Why Analysts See Bright Prospects for This Hospital Chain
The Quiet Pause: Why Clean Science & Tech Might Just Be Catching Its Breath

The Quiet Pause: Why Clean Science & Tech Might Just Be Catching Its Breath
Zydus Lifesciences: Decoding the Bull Case — Why Analysts Are Eyeing This Pharma Powerhouse

Zydus Lifesciences: Decoding the Bull Case — Why Analysts Are Eyeing This Pharma Powerhouse
The Grand Old Elephant Takes Flight: Why LIC Might Just Be Your Next Big Investment Story

The Grand Old Elephant Takes Flight: Why LIC Might Just Be Your Next Big Investment Story
The Pulse of Health: Why One Diagnostic Giant Might Just Be Poised for a New Chapter

The Pulse of Health: Why One Diagnostic Giant Might Just Be Poised for a New Chapter
Jim Cramer's Zoom Verdict: A Search for Spark in a Stagnant Market, and Why He's Just Not Seeing It

Jim Cramer's Zoom Verdict: A Search for Spark in a Stagnant Market, and Why He's Just Not Seeing It
KFIN Technologies: Why This Often-Overlooked Player Is Catching the Eye of Market Mavens

KFIN Technologies: Why This Often-Overlooked Player Is Catching the Eye of Market Mavens
Federal Bank's Quiet Strength: Why Analysts Are Betting Big on Its Future

Federal Bank's Quiet Strength: Why Analysts Are Betting Big on Its Future
When Sports Triumphs Meet Stock Market Wins: Unpacking Citi's Bullish Call on MSG Sports

When Sports Triumphs Meet Stock Market Wins: Unpacking Citi's Bullish Call on MSG Sports
HCL Tech Shines Bright: Why Deven Choksey Recommends Accumulation with a Rs 1628 Target!

HCL Tech Shines Bright: Why Deven Choksey Recommends Accumulation with a Rs 1628 Target!
Sky-High Potential: Why Needham Sees AeroVironment As a Drone Stock Powerhouse

Sky-High Potential: Why Needham Sees AeroVironment As a Drone Stock Powerhouse
Unpacking Apar Industries: Why Prabhudas Lilladher Recommends a 'Hold' with a Rs 9,540 Target

Unpacking Apar Industries: Why Prabhudas Lilladher Recommends a 'Hold' with a Rs 9,540 Target
Cramer's Caution: Why Micron Needs to Cool Down Before Taking Flight

Cramer's Caution: Why Micron Needs to Cool Down Before Taking Flight
Unlocking Value: Why Analysts are Bullish on CESC with a Rs 195 Target!

Unlocking Value: Why Analysts are Bullish on CESC with a Rs 195 Target!
Savoring Success: Why Apex Frozen Foods is a Catch for Investors, Targeting a Delicious Rs 284!

Savoring Success: Why Apex Frozen Foods is a Catch for Investors, Targeting a Delicious Rs 284!
Max Healthcare Soars: Nuvama Recommends 'Buy' with Ambitious Rs 970 Target Price!

Max Healthcare Soars: Nuvama Recommends 'Buy' with Ambitious Rs 970 Target Price!
SRF Shares Set to Soar: Analysts Project Ambitious Rs 3540 Target

SRF Shares Set to Soar: Analysts Project Ambitious Rs 3540 Target
Polycab India: Why Analysts See a Bright Future and an Rs 8440 Target Price

Polycab India: Why Analysts See a Bright Future and an Rs 8440 Target Price
ICICI Bank Set to Soar: Emkay Global Bullish on Banking Giant with Rs 1700 Target!

ICICI Bank Set to Soar: Emkay Global Bullish on Banking Giant with Rs 1700 Target!
Unlocking Value: Why Motilal Oswal Recommends Buying JSW Infrastructure with a Rs 380 Target

Unlocking Value: Why Motilal Oswal Recommends Buying JSW Infrastructure with a Rs 380 Target
Investment Spotlight: Why Deven Choksey Recommends Accumulating Anupam Rasayan India

Investment Spotlight: Why Deven Choksey Recommends Accumulating Anupam Rasayan India
Max Healthcare: Why Analysts Are Bullish on a Bright Future and a Rs 1355 Target!

Max Healthcare: Why Analysts Are Bullish on a Bright Future and a Rs 1355 Target!
SAMHI Hotels: Why This Hospitality Gem Is Poised for a 65% Surge

SAMHI Hotels: Why This Hospitality Gem Is Poised for a 65% Surge
Unlocking Potential: Why Glenmark Pharma is Poised for a Massive Upswing

Unlocking Potential: Why Glenmark Pharma is Poised for a Massive Upswing
Nuvama Wealth Poised for Prosperity: Why Analysts See a Robust 'Buy'

Nuvama Wealth Poised for Prosperity: Why Analysts See a Robust 'Buy'
Unlocking Value: Why Vinati Organics Is a 'Buy' with a Rs 2180 Target

Unlocking Value: Why Vinati Organics Is a 'Buy' with a Rs 2180 Target
Alkyl Amines Chemicals: Navigating Headwinds, Motilal Oswal Maintains Neutral Stance

Alkyl Amines Chemicals: Navigating Headwinds, Motilal Oswal Maintains Neutral Stance
Is Deepak Nitrite's Shine Fading? Motilal Oswal Says 'Sell'!

Is Deepak Nitrite's Shine Fading? Motilal Oswal Says 'Sell'!
Unlocking Value: Why Ashok Leyland is a 'Buy' with a Rs 141 Target!

Unlocking Value: Why Ashok Leyland is a 'Buy' with a Rs 141 Target!
IndoStar Capital Finance: Why Motilal Oswal Sees a Soaring Future at Rs 330!

IndoStar Capital Finance: Why Motilal Oswal Sees a Soaring Future at Rs 330!
Load more..